C9 抗体
(Complement Component C9 (C9))
This gene encodes the final component of the complement system. It participates in the formation of the Membrane Attack Complex (MAC). The MAC assembles on bacterial membranes to form a pore, permitting disruption of bacterial membrane organization. Mutations in this gene cause component C9 deficiency. [provided by RefSeq, Feb 2009].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| C9 抗体 (AA 161-260) (AbBy Fluor® 750) | 人 | 兔 Polyclonal |
|
|
|
| C9 抗体 (AA 161-260) (AbBy Fluor® 350) | 人 | 兔 Polyclonal |
|
|
|
| C9 抗体 (AA 161-260) (AbBy Fluor® 488) | 人 | 兔 Polyclonal |
|
|
|
| C9 抗体 (AA 161-260) | 人 | 兔 Polyclonal |
|
|
|
| C9 抗体 (AA 139-519) | 兔 | 兔 Polyclonal |
|
|
|
| C9 抗体 (AA 22-265) | 人 | 兔 Polyclonal |
|
|
|
| Recombinant C9 抗体 (C-Term) | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant C9 抗体 (C-Term) | 人 | 小鼠 Monoclonal |
|
|
|
| C9 抗体 (AA 191-220) (PE) | 人 | 兔 Polyclonal |
|
|
|
| C9 抗体 (AA 191-220) (Alkaline Phosphatase (AP)) | 人 | 兔 Polyclonal |
|
|
|
| C9 抗体 (AA 191-220) (APC) | 人 | 兔 Polyclonal |
|
|
|
| C9 抗体 (AA 191-220) | 人 | 兔 Polyclonal |
|
|
|
| C9 抗体 (FITC) | 人 | 小鼠 Monoclonal |
|
|
|
| C9 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| C9 抗体 (AA 191-220) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| C9 抗体 (AA 191-220) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| C9 抗体 (AA 191-220) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| C9 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| C9 抗体 | 人 | 山羊 Polyclonal |
|
|
|
| C9 抗体 | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 750
- 抗体亚型
- IgG
- 抗原表位
- AA 161-260
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 350
- 抗体亚型
- IgG
- 抗原表位
- AA 161-260
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 488
- 抗体亚型
- IgG
- 抗原表位
- AA 161-260
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 161-260
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 兔
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 139-519
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 22-265
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- r10A6
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1, kappa
- 抗原表位
- C-Term
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- r10A6
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1, kappa
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 191-220
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Alkaline Phosphatase (AP)
- 抗体亚型
- IgG
- 抗原表位
- AA 191-220
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 191-220
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 191-220
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- Func (Functional Studies: 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 标记
- FITC
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- Func (Functional Studies: 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 标记
- unconjugated
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 191-220
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 191-220
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 191-220
Latest Publications for our C9 抗体
: "Diabetes-related changes in the protein composition and the biomechanical properties of human retinal vascular basement membranes." in: PLoS ONE, Vol. 12, Issue 12, pp. e0189857, (2018) (PubMed).
: "Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 32, Issue 5, pp. 2574-2586, (2018) (PubMed).
: "Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice." in: Scientific reports, Vol. 6, pp. 30239, (2016) (PubMed).
: "Selectivity analysis of single binder assays used in plasma protein profiling." in: Proteomics, Vol. 13, Issue 23-24, pp. 3406-10, (2013) (PubMed).
: "Defining the CD59-C9 binding interaction." in: The Journal of biological chemistry, Vol. 281, Issue 37, pp. 27398-404, (2006) (PubMed).
: "The human complement C9 gene: structural analysis of the 5' gene region and genetic polymorphism studies." in: European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics, Vol. 28, Issue 5, pp. 515-22, (2002) (PubMed).
: "Induction of complement C9 messenger RNAs in human neuronal cells by inflammatory stimuli: relevance to neurodegenerative disorders." in: Experimental gerontology, Vol. 36, Issue 7, pp. 1179-88, (2001) (PubMed).
: "Analysis of C5b-8 binding sites in the C9 molecule using monoclonal antibodies: participation of two separate epitopes of C9 in C5b-8 binding." in: Molecular immunology, Vol. 29, Issue 7-8, pp. 911-6, (1992) (PubMed).
: "Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 32, Issue 5, pp. 2574-2586, (2018) (PubMed).
: "Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice." in: Scientific reports, Vol. 6, pp. 30239, (2016) (PubMed).
: "Selectivity analysis of single binder assays used in plasma protein profiling." in: Proteomics, Vol. 13, Issue 23-24, pp. 3406-10, (2013) (PubMed).
: "Defining the CD59-C9 binding interaction." in: The Journal of biological chemistry, Vol. 281, Issue 37, pp. 27398-404, (2006) (PubMed).
: "The human complement C9 gene: structural analysis of the 5' gene region and genetic polymorphism studies." in: European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics, Vol. 28, Issue 5, pp. 515-22, (2002) (PubMed).
: "Induction of complement C9 messenger RNAs in human neuronal cells by inflammatory stimuli: relevance to neurodegenerative disorders." in: Experimental gerontology, Vol. 36, Issue 7, pp. 1179-88, (2001) (PubMed).
: "Analysis of C5b-8 binding sites in the C9 molecule using monoclonal antibodies: participation of two separate epitopes of C9 in C5b-8 binding." in: Molecular immunology, Vol. 29, Issue 7-8, pp. 911-6, (1992) (PubMed).
Aliases for C9 抗体
complement C9 (C9) 抗体complement C9 (c9) 抗体
complement component 9 (C9) 抗体
complement component 9 L homeolog (c9.L) 抗体
complement component 9 (c9) 抗体
c9 抗体
LOC100037951 抗体
LOC100136130 抗体
wu:fb60b05 抗体
wu:fd50e04 抗体
zgc:112272 抗体
您还需要查找其他产品吗？
You are here:
